Literature DB >> 22010508

Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.

Richard Lumb1, Ivan Bastion, Robyn Carter, Peter Jelfs, Terillee Keehner, Aina Sievers.   

Abstract

There were 886 and 1,062 bacteriologically-confirmed cases of tuberculosis (TB) in 2008 and 2009, representing an annual rate of 4.1 and 4.9 cases per 100,000 population respectively. Over the 2 years, a total of 23 children aged under 10 years (male n = 13, female n = 10) had bacteriologically confirmed tuberculosis, including 3 children with TB meningitis. Results of in vitro drug susceptibility testing were available for 885 of 886 and 1,060 of 1,062 isolates for isoniazid (INH), rifampicin (RIF), ethambutol (EMB), and pyrazinamide (PYZ) in 2008 and 2009 respectively. In 2008, a total of 94 (10.7%) isolates of Mycobacterium tuberculosis complex were resistant to at least one of the anti-tuberculosis agents. Any resistance to INH was noted for 76 (8.7%), 23 (2.6%) for RIF, 10 (1.1%) for EMB and 9 (1.0%) for PYZ. Resistance to at least INH and RIF (defined as multidrug-resistant TB (MDR-TB) was detected in 21 (2.4%) isolates. None of the 21 MDR-TB isolates had resistance to either ofloxacin or the injectable agents. In 2009, a total of 168 (15.9%) were resistant to at least one of the anti-TB agents. Any resistance to INH was noted for 150 (14.2%) isolates, 37 (3.5%) for RIF, 5 (0.5%) for EMB and 13 (1.2%) for PYZ. A total of 31 (2.9%) isolates were MDR-TB. In 2009, there were 2 cases of quinolone resistance in MDR-TB from persons born overseas. Mono-resistance to INH was the most commonly detected resistance with 33 and 80 isolates in 2008 and 2009, respectively. Mono-resistance to RIF was infrequently encountered with 2 and 5 isolates in 2008 and 2009 respectively. There were six and 11 MDR-TB patients from the Papua New Guinea (PNG) - Torres Strait Islands (TSI) cross-border region in 2008 and 2009 respectively. The PNG-TSI zone now contributes a substantial proportion of MDR-TB cases to the database. In addition, there were 24 isolates of Mycobacterium bovis bacille Calmette Guérin (BCG), 15 were cultured from males (4 aged < or = 5 years) and from 9 females (5 aged < or = 5 years). The predominant site of isolation was from vaccination abscess. Eight males (range: 57-87 years) had M. bovis BCG isolated from urine or blood culture.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22010508

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  8 in total

1.  Genotyping and Prevalence of Pyrazinamide- and Moxifloxacin-Resistant Tuberculosis in China, 2000 to 2010.

Authors:  Yu Pang; Zhijian Zhang; Yufeng Wang; Shengfen Wang; Yuanyuan Song; Bing Zhao; Yang Zhou; Xichao Ou; Qiang Li; Hui Xia; Yang Zheng; Xiangqun Fang; Yanlin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 2.  Tuberculosis and mental health in the Asia-Pacific.

Authors:  Paul H Mason; Annika C Sweetland; Greg J Fox; Shaun Halovic; Thu Anh Nguyen; Guy B Marks
Journal:  Australas Psychiatry       Date:  2016-05-20       Impact factor: 1.369

3.  Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.

Authors:  Ekaterina V Kurbatova; Joseph S Cavanaugh; Tracy Dalton; Eleanor S Click; J Peter Cegielski
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

4.  Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea.

Authors:  Serej D Ley; Paul Harino; Kilagi Vanuga; Ruben Kamus; Robyn Carter; Christopher Coulter; Sushil Pandey; Julia Feldmann; Marie Ballif; Peter M Siba; Suparat Phuanukoonnon; Sebastien Gagneux; Hans-Peter Beck
Journal:  BMC Microbiol       Date:  2014-12-05       Impact factor: 3.605

5.  Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia.

Authors:  Ulziijargal Gurjav; Peter Jelfs; Nadine McCallum; Ben J Marais; Vitali Sintchenko
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

6.  Epidemiology, Diagnosis and Management of Extra-Pulmonary Tuberculosis in a Low-Prevalence Country: A Four Year Retrospective Study in an Australian Tertiary Infectious Diseases Unit.

Authors:  Simon Pollett; Pamela Banner; Matthew V N O'Sullivan; Anna P Ralph
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

7.  Case Report: Disseminated, rifampicin resistant Mycobacterium bovis (BCG) infection in an immunocompromised child.

Authors:  Simon B Drysdale; Dominic F Kelly; Marcus Morgan; Tim Peto; Derrick Crook; Philippa C Matthews; Timothy M Walker
Journal:  Wellcome Open Res       Date:  2020-10-15

8.  Atypical mycobacterial infection mimicking metastatic cholangiocarcinoma.

Authors:  Harsh A Kanhere; Markus I Trochsler; John Pierides; Guy J Maddern
Journal:  J Surg Case Rep       Date:  2013-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.